NAS:CNCR

Range Cancer Therapeutics ETF

$ 9.9305 -0.2295 ( -2.26%) 09:41 AM EST
PE Ratio:
15.79
PB Ratio:
1.62
Volume:
907.00
Dividend Yield %:
0
Last Holding update 2025-01-29 75 Stocks (1 new)
Value $12.00 Mil Turnover 19 %
Portfolio Report
Registrant: Range Cancer Therapeutics ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
This section is for Premium GuruFocus Premium Icon Membership subscribers only.
GuruFocus Premium GuruFocus Premium Icon Membership
  30-year financial data
  All-in-one screener
  Graham, Buffett, and Lynch value screens
  Manual of Stocks
  Interactive charts
  Warning signs
  Real time Guru picks and Portfolios
  Excel Add-In, API (2000 queries/month)

Discussions on Range Cancer Therapeutics ETF

User's Avatar
How would you rate this stock? CNCR
No discussions yet.